
A collision of drug criminalization, inadequate and discriminatory housing policies, and insufficient mental health and substance use care services has fostered open drug scene encampments in communities around the world.
A collision of drug criminalization, inadequate and discriminatory housing policies, and insufficient mental health and substance use care services has fostered open drug scene encampments in communities around the world.
Throughout our Connecting Care podcast series, we’ve focused on different communities of adults with HIV and/or substance use disorders (SUDs). One population we haven’t yet covered is the adolescent and young adult population.
Methadone can be a life-changing treatment option for people with opioid use disorder. However, a number of federal and state regulations and logistical requirements can inhibit a person’s ability to start and/or maintain methadone treatment.
The Americans with Disabilities Act (ADA) is a federal civil rights statute that was enacted in 1990 to protect individuals with disabilities from discrimination by employers, state and local government, and public-serving entities.
Building on last month’s episode about providing HIV and substance use care for people who are incarcerated, this month the Boston Medical Center Team talks with Dr.
Navigating the HIV and substance use systems of care presents a number of unique challenges, many of which can become more complex depending on a person’s housing, employment, mental health, or economic situation.
In response to an increased risk of overdose, several communities in the U.S. are considering establishing spaces for people to use substances safely.
The growing opioid crisis across the United States has resulted in an increase in new HIV diagnoses.
This month’s Connecting Care episode is the second in a two-part series about treatment for Hepatitis C Virus (HCV) among people with opioid use disorder.
This month’s Connecting Care episode is the first in a two-part series about treatment for Hepatitis C Virus (HCV) among people with opioid use disorder.